Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Schutkowski

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer CompoundsEmre F Bülbül, Dina Robaa, Ping Sun, et al.
Frontiers in Immunology|November 24, 2015
PKC-Theta is a Novel SC35 Splicing Factor Regulator in Response to T Cell ActivationRobert Duncan McCuaig, Jennifer Dunn, Jasmine Li, et al.
Biochemical and Biophysical Research Communications|April 23, 2011
Identification of a core domain within the proregion of bone morphogenetic proteins that interacts with the dimeric, mature domainSilke Kuhfahl, Anja Hauburger, Tino Thieme, et al.
Bioorganic Chemistry|October 18, 2024
Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degradersHany S Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Analytical Biochemistry|February 10, 2007
Affinity profiling using the peptide microarray technology: a case studyVictor Tapia, Juliane Bongartz, Mike Schutkowski, et al.
Journal of Molecular Biology|October 15, 2018
Regulation of the Minichromosome Maintenance Protein 3 (MCM3) Chromatin Binding by the Prolyl Isomerase Pin1Michael Schumann, Miroslav Malešević, Erik Hinze, et al.
Archiv Der Pharmazie|July 12, 2024
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activityFady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
Biotechnology Advances|July 12, 2011
The protein interaction network mediated by human SH3 domainsMartina Carducci, Livia Perfetto, Leonardo Briganti, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1-3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell LinesMohamed Abdelsalam, Hany S Ibrahim, Lukas Krauss, et al.
Bioorganic & Medicinal Chemistry|June 11, 2015
Identification of peptidic substrates for the human kinase Myt1 using peptide microarraysAlexander Rohe, Charlott Platzer, Antonia Masch, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer CompoundsEmre F Bülbül, Dina Robaa, Ping Sun, et al.
Frontiers in Immunology|November 24, 2015
PKC-Theta is a Novel SC35 Splicing Factor Regulator in Response to T Cell ActivationRobert Duncan McCuaig, Jennifer Dunn, Jasmine Li, et al.
Biochemical and Biophysical Research Communications|April 23, 2011
Identification of a core domain within the proregion of bone morphogenetic proteins that interacts with the dimeric, mature domainSilke Kuhfahl, Anja Hauburger, Tino Thieme, et al.
Bioorganic Chemistry|October 18, 2024
Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degradersHany S Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Analytical Biochemistry|February 10, 2007
Affinity profiling using the peptide microarray technology: a case studyVictor Tapia, Juliane Bongartz, Mike Schutkowski, et al.
Journal of Molecular Biology|October 15, 2018
Regulation of the Minichromosome Maintenance Protein 3 (MCM3) Chromatin Binding by the Prolyl Isomerase Pin1Michael Schumann, Miroslav Malešević, Erik Hinze, et al.
Archiv Der Pharmazie|July 12, 2024
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activityFady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
Biotechnology Advances|July 12, 2011
The protein interaction network mediated by human SH3 domainsMartina Carducci, Livia Perfetto, Leonardo Briganti, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1-3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell LinesMohamed Abdelsalam, Hany S Ibrahim, Lukas Krauss, et al.
Bioorganic & Medicinal Chemistry|June 11, 2015
Identification of peptidic substrates for the human kinase Myt1 using peptide microarraysAlexander Rohe, Charlott Platzer, Antonia Masch, et al.
Pageof 11